Fabry disease: detection of 13-bp deletion in alpha-galactosidase A gene and its application to gene diagnosis of heterozygotes
- PMID: 1650161
- DOI: 10.1002/ana.410290517
Fabry disease: detection of 13-bp deletion in alpha-galactosidase A gene and its application to gene diagnosis of heterozygotes
Abstract
Polymerase chain reaction amplification of reverse-transcribed messenger RNA from a patient with Fabry disease revealed a 13-base pair deletion in the 5' region (exon 1) of alpha-galactosidase A complementary DNA. This gene rearrangement was not detected by Southern or Northern analysis. Short direct repeats were present around the breakpoints, and considered to be of pathogenetic significance. Gene diagnosis of the mother and a female cousin was successfully achieved by polymerase chain reaction amplification of genomic DNA; the former as a Fabry disease heterozygote and the latter as a normal homozygote.
Similar articles
-
Fabry disease: detection of gene rearrangements in the human alpha-galactosidase A gene by multiplex PCR amplification.Hum Mutat. 1993;2(2):108-11. doi: 10.1002/humu.1380020208. Hum Mutat. 1993. PMID: 8318986
-
Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes.J Investig Med. 2000 Jul;48(4):227-35. J Investig Med. 2000. PMID: 10916280
-
A missense mutation, A156T, in the alpha-galactosidase A gene causes typical Fabry disease.Clin Nephrol. 2001 Mar;55(3):243-7. Clin Nephrol. 2001. PMID: 11316246
-
Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene.Hum Mutat. 1994;3(2):103-11. doi: 10.1002/humu.1380030204. Hum Mutat. 1994. PMID: 7911050 Review.
-
[Molecular genetics of inherited metabolic diseases--its application to the investigation of pathogenesis and the diagnosis of Fabry disease].Rinsho Byori. 1994 Jun;42(6):628-35. Rinsho Byori. 1994. PMID: 7914243 Review. Japanese.
Cited by
-
Alpha-galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins.Hum Genet. 1995 May;95(5):557-61. doi: 10.1007/BF00223869. Hum Genet. 1995. PMID: 7759078
-
Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene.J Med Genet. 1996 Aug;33(8):682-8. doi: 10.1136/jmg.33.8.682. J Med Genet. 1996. PMID: 8863162 Free PMC article.
-
Alpha-galactosidase transgenic mouse: heterogeneous gene expression and posttranslational glycosylation in tissues.Glycoconj J. 1998 Jun;15(6):591-4. doi: 10.1023/a:1006915926732. Glycoconj J. 1998. PMID: 9881765
-
A carboxy-terminal truncation of human alpha-galactosidase A in a heterozygous female with Fabry disease and modification of the enzymatic activity by the carboxy-terminal domain. Increased, reduced, or absent enzyme activity depending on number of amino acid residues deleted.J Clin Invest. 1996 Oct 15;98(8):1809-17. doi: 10.1172/JCI118981. J Clin Invest. 1996. PMID: 8878432 Free PMC article.
-
Stroke in Fabry's disease.J Neurol. 1994 Jan;241(3):153-6. doi: 10.1007/BF00868342. J Neurol. 1994. PMID: 8164017
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical